May 28, 2024, 08:56
Angelo Pirozzi: CAR-T cells targeting claudin18.2 in pretreated advanced PDAC by Changsong Qi et al.
Angelo Pirozzi, Medical Oncology Fellow at Humanitas University and Research Fellow at Mayo Clinic (Phoenix), made the following post on X:
”CAR-T cells targeting claudin-18.2 in pretreated advanced PDAC.
- 2 phase I/Ib trials with 24 patients.
- 79% ≥2 previous systemic lines.
- ORR 16.7%.
- DCR 70.8%.
- mPFS 3.3 months.
- mOS 10.0 months.
- mDoR 9.5 months.”
Read further.
Source: Angelo Pirozzi/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48
Nov 13, 2024, 23:46